ProQR Therapeutics NV banner

Wall St Price Targets

PRQR Price Forecast
Based on 12 analysts

+514% Upside
from $1.33 today

ProQR Therapeutics NV (PRQR)’s 12-month stock price forecast through October 2027 has a consensus target of $8.16, implying 514% upside. The forecast is based on price targets from 12 Wall Street analysts.

PRQR Analyst Rating
Based on 9 analysts

avg. 4.89 of 5
Strong buy
8 89%
Buy
1 11%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate PRQR Strong buy, with 9 of 9 recommending Buy or Strong buy.

ProQR Therapeutics NV Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Value YoY Lowest–highest Analysts
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PRQR's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for PRQR is 8.16 USD with a low forecast of 3.03 USD and a high forecast of 15.75 USD.

What is the Revenue forecast for ProQR Therapeutics NV?
Projected CAGR
50%

Over the last 12 years, the compound annual growth rate for Revenue has been 51%. The projected CAGR for the next 8 years is 50%.

Back to Top